374 related articles for article (PubMed ID: 37525595)
1. Overview of Alcohol Use Disorder.
Kranzler HR
Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
3. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Williams EC; Matson TE; Harris AHS
Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
[TBL] [Abstract][Full Text] [Related]
4. Review of Evidence-Based Strategies to Treat Alcohol Use Disorder.
Worley J
J Psychosoc Nurs Ment Health Serv; 2021 Dec; 59(12):7-11. PubMed ID: 34846245
[TBL] [Abstract][Full Text] [Related]
5. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
7. Advances in Pharmacotherapy Development: Human Clinical Studies.
Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
[TBL] [Abstract][Full Text] [Related]
8. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
[TBL] [Abstract][Full Text] [Related]
10. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
[TBL] [Abstract][Full Text] [Related]
11. Medications for Alcohol Use Disorder.
Poorman E; McQuade BM; Messmer S
Am Fam Physician; 2024 Jan; 109(1):71-78. PubMed ID: 38227873
[TBL] [Abstract][Full Text] [Related]
12. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
[TBL] [Abstract][Full Text] [Related]
13. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
[No Abstract] [Full Text] [Related]
14. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
15. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
Castrén S; Mäkelä N; Alho H
Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
[TBL] [Abstract][Full Text] [Related]
16. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
[TBL] [Abstract][Full Text] [Related]
17. Alcohol Use Disorder: The Role of Medication in Recovery.
Mason BJ; Heyser CJ
Alcohol Res; 2021; 41(1):07. PubMed ID: 34113531
[TBL] [Abstract][Full Text] [Related]
18. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
Abraham AJ; Knudsen HK; Roman PM
J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
Lohoff FW
Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
